Hyundai Pharm Cash Flow Reinvestment Rate
Hyundai Pharm cash flow reinvestment rate. Hyundai Pharm (004310) has a Cash Flow Reinvestment Rate of 5.06x as of May 2026, reinvesting ₩12.10 Billion (capex ₩1.09 Billion plus investments ₩-11.01 Billion) from operating cash flow of ₩2.39 Billion. See how financially flexible is Hyundai Pharm to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hyundai Pharm (2010–2022)
Cash flow reinvestment rate of Hyundai Pharm from 2010 to 2022. Historical reinvestment intensity for Hyundai Pharm across 8 annual periods. Explore cash flow to debt ratio of Hyundai Pharm to assess how comfortably operating cash covers total debt obligations.
Hyundai Pharm Cash Flow Reinvestment Rate by Year (2010–2022)
Hyundai Pharm cash flow reinvestment rate by year from 2010 to 2022. Year-by-year capital reinvestment analysis for Hyundai Pharm. For the full cash flow conversion analysis, see cash efficiency ratio of Hyundai Pharm.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.43x | ₩16.57 Billion | ₩11.62 Billion | ₩6.58 Billion | ▲ +7.0% |
| 2021 | 1.33x | ₩6.84 Billion | ₩5.13 Billion | ₩6.81 Billion | ▼ -23.4% |
| 2020 | 1.74x | ₩18.79 Billion | ₩10.80 Billion | ₩6.40 Billion | ▲ +138.0% |
| 2019 | 0.73x | ₩5.09 Billion | ₩6.96 Billion | ₩2.36 Billion | ▼ -74.6% |
| 2018 | 2.87x | ₩8.14 Billion | ₩2.83 Billion | ₩2.67 Billion | ▲ +727.5% |
| 2013 | 0.35x | ₩2.76 Billion | ₩7.95 Billion | ₩2.24 Billion | ▼ -45.2% |
| 2011 | 0.63x | ₩3.97 Billion | ₩6.27 Billion | ₩3.68 Billion | ▼ -58.9% |
| 2010 | 1.54x | ₩4.13 Billion | ₩2.68 Billion | ₩3.95 Billion | — |